- Home
- RXRX vs CNMD Comparison
RXRX vs CNMD Comparison
Compare RXRX & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXRX
- CNMD
- Stock Information
- Founded
- RXRX 2013
- CNMD 1970
- Country
- RXRX United States
- CNMD United States
- Employees
- RXRX N/A
- CNMD N/A
- Industry
- RXRX Biotechnology: Pharmaceutical Preparations
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RXRX Health Care
- CNMD Health Care
- Exchange
- RXRX Nasdaq
- CNMD Nasdaq
- Market Cap
- RXRX 2.0B
- CNMD 1.7B
- IPO Year
- RXRX 2021
- CNMD 1987
- Fundamental
- Price
- RXRX $5.28
- CNMD $51.64
- Analyst Decision
- RXRX Buy
- CNMD Hold
- Analyst Count
- RXRX 5
- CNMD 5
- Target Price
- RXRX $7.00
- CNMD $62.20
- AVG Volume (30 Days)
- RXRX 29.9M
- CNMD 439.0K
- Earning Date
- RXRX 08-07-2025
- CNMD 07-30-2025
- Dividend Yield
- RXRX N/A
- CNMD 1.49%
- EPS Growth
- RXRX N/A
- CNMD 46.38
- EPS
- RXRX N/A
- CNMD 3.81
- Revenue
- RXRX $59,790,000.00
- CNMD $1,315,998,000.00
- Revenue This Year
- RXRX $23.51
- CNMD $6.27
- Revenue Next Year
- RXRX $53.87
- CNMD $5.62
- P/E Ratio
- RXRX N/A
- CNMD $13.45
- Revenue Growth
- RXRX 29.32
- CNMD 4.32
- 52 Week Low
- RXRX $3.79
- CNMD $46.00
- 52 Week High
- RXRX $12.36
- CNMD $78.19
- Technical
- Relative Strength Index (RSI)
- RXRX 52.46
- CNMD 41.34
- Support Level
- RXRX $4.80
- CNMD $51.20
- Resistance Level
- RXRX $5.88
- CNMD $54.81
- Average True Range (ATR)
- RXRX 0.38
- CNMD 1.83
- MACD
- RXRX 0.03
- CNMD 0.07
- Stochastic Oscillator
- RXRX 48.32
- CNMD 22.00
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.